Total Payments
$912.70
2024 Payments
$54.14
Companies
7
Transactions
15
Medicare Patients
281
Medicare Billing
$174,254
Payment Breakdown by Category
Food & Beverage$912.70 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $912.70 | 15 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $294.63 | 3 | $0 (2024) |
| Allergan, Inc. | $293.61 | 3 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $125.00 | 1 | $0 (2021) |
| Veloxis Pharmaceuticals, Inc. | $80.81 | 4 | $0 (2019) |
| Astellas Pharma Global Development | $68.19 | 1 | $0 (2017) |
| INTERCEPT PHARMACEUTICALS, INC. | $25.88 | 1 | $0 (2022) |
| Mallinckrodt LLC | $24.58 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $54.14 | 1 | ABBVIE INC. ($54.14) |
| 2023 | $240.49 | 2 | ABBVIE INC. ($240.49) |
| 2022 | $228.60 | 3 | Allergan, Inc. ($202.72) |
| 2021 | $215.89 | 2 | SANOFI-AVENTIS U.S. LLC ($125.00) |
| 2019 | $10.82 | 1 | Veloxis Pharmaceuticals, Inc. ($10.82) |
| 2018 | $24.40 | 1 | Veloxis Pharmaceuticals, Inc. ($24.40) |
| 2017 | $138.36 | 5 | Astellas Pharma Global Development ($68.19) |
All Payment Transactions
15 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/08/2024 | ABBVIE INC. | STRATTICE RECONSTRUCTIVE TISSUE MATRIX BPS (Device) | Food and Beverage | In-kind items and services | $54.14 | General |
| Category: TRAUMA EMERGENCY, INJURY, SURGERY | ||||||
| 12/12/2023 | ABBVIE INC. | STRATTICE RECONSTRUCTIVE TISSUE MATRIX BPS (Device) | Food and Beverage | In-kind items and services | $134.35 | General |
| Category: TRAUMA EMERGENCY, INJURY, SURGERY | ||||||
| 09/12/2023 | ABBVIE INC. | STRATTICE RECONSTRUCTIVE TISSUE MATRIX BPS (Device) | Food and Beverage | In-kind items and services | $106.14 | General |
| Category: TRAUMA EMERGENCY, INJURY, SURGERY | ||||||
| 10/11/2022 | Allergan, Inc. | STRATTICE RECONSTRUCTIVE TISSUE MATRIX BPS (Device) | Food and Beverage | In-kind items and services | $122.27 | General |
| Category: TRAUMA EMERGENCY, INJURY, SURGERY | ||||||
| 08/02/2022 | INTERCEPT PHARMACEUTICALS, INC. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $25.88 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 06/14/2022 | Allergan, Inc. | STRATTICE RECONSTRUCTIVE TISSUE MATRIX BPS (Device) | Food and Beverage | In-kind items and services | $80.45 | General |
| Category: TRAUMA EMERGENCY, INJURY, SURGERY | ||||||
| 12/02/2021 | SANOFI-AVENTIS U.S. LLC | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 11/09/2021 | Allergan, Inc. | STRATTICE RECONSTRUCTIVE TISSUE MATRIX BPS (Device) | Food and Beverage | In-kind items and services | $90.89 | General |
| Category: TRAUMA EMERGENCY, INJURY, SURGERY | ||||||
| 07/18/2019 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug), Envarsus | Food and Beverage | In-kind items and services | $10.82 | General |
| Category: Immunosuppressant | ||||||
| 11/08/2018 | Veloxis Pharmaceuticals, Inc. | Envarsus XR (SP) (Drug), Envarsus XR, Envarsus XR | Food and Beverage | In-kind items and services | $24.40 | General |
| Category: Immunosuppressant | ||||||
| 12/07/2017 | Mallinckrodt LLC | OFIRMEV (Drug) | Food and Beverage | In-kind items and services | $12.20 | General |
| Category: ACUTE CARE | ||||||
| 11/09/2017 | Veloxis Pharmaceuticals, Inc. | Envarsus XR (Drug), Envarsus XR, Envarsus XR | Food and Beverage | In-kind items and services | $25.39 | General |
| Category: Immunosuppressant | ||||||
| 06/27/2017 | Astellas Pharma Global Development | Astagraf (Drug) | Food and Beverage | In-kind items and services | $68.19 | General |
| Category: Immunology | ||||||
| 05/04/2017 | Mallinckrodt LLC | OFIRMEV (Drug) | Food and Beverage | In-kind items and services | $12.38 | General |
| Category: ACUTE CARE | ||||||
| 04/13/2017 | Veloxis Pharmaceuticals, Inc. | Envarsus XR (Drug), Envarsus XR, Envarsus XR | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: Immunosuppressant | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 35 | 65 | $31,080 | $7,470 |
| 2022 | 4 | 72 | 131 | $206,265 | $44,163 |
| 2021 | 8 | 148 | 297 | $369,757 | $87,819 |
| 2020 | 2 | 26 | 26 | $181,612 | $34,803 |
Total Patients
281
Total Services
519
Medicare Billing
$174,254
Procedure Codes
16
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 24 | 24 | $19,664 | $4,507 | 22.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 11 | 41 | $11,416 | $2,962 | 25.9% |
| 50360 | Transplantation of donor kidney | Facility | 2022 | 15 | 15 | $157,890 | $33,229 | 21.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 21 | 80 | $22,120 | $5,322 | 24.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 20 | 20 | $15,839 | $4,134 | 26.1% |
| 50323 | Preparation of donor kidney for transplantation | Facility | 2022 | 16 | 16 | $10,416 | $1,477 | 14.2% |
| 50360 | Transplantation of donor kidney | Facility | 2021 | 25 | 26 | $273,676 | $62,633 | 22.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 30 | 159 | $43,884 | $10,858 | 24.7% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 17 | 17 | $7,735 | $3,694 | 47.8% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 12 | 30 | $6,614 | $2,964 | 44.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 13 | 14 | $10,837 | $2,666 | 24.6% |
| 50323 | Preparation of donor kidney for transplantation | Facility | 2021 | 25 | 25 | $16,275 | $2,101 | 12.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 15 | 15 | $6,105 | $1,517 | 24.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 11 | 11 | $4,631 | $1,386 | 29.9% |
| 50360 | Transplantation of donor kidney | Facility | 2020 | 13 | 13 | $125,310 | $33,665 | 26.9% |
| 50323 | Preparation of donor kidney for transplantation | Facility | 2020 | 13 | 13 | $56,302 | $1,138 | 2.0% |
About Dr. Devon John, M.D
Dr. Devon John, M.D is a Transplant Surgery healthcare provider based in Valhalla, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/05/2005. The National Provider Identifier (NPI) number assigned to this provider is 1932196862.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Devon John, M.D has received a total of $912.70 in payments from pharmaceutical and medical device companies, with $54.14 received in 2024. These payments were reported across 15 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($912.70).
As a Medicare-enrolled provider, John has provided services to 281 Medicare beneficiaries, totaling 519 services with total Medicare billing of $174,254. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Ad
Practice Information
- Specialty Transplant Surgery
- Location Valhalla, NY
- Active Since 10/05/2005
- Last Updated 02/22/2021
- Taxonomy Code 204F00000X
- Entity Type Individual
- NPI Number 1932196862
Products in Payments
- STRATTICE RECONSTRUCTIVE TISSUE MATRIX BPS (Device) $588.24
- Astagraf (Drug) $68.19
- Envarsus XR (Drug) $45.59
- OCALIVA (Drug) $25.88
- OFIRMEV (Drug) $24.58
- Envarsus XR (SP) (Drug) $24.40
- Envarsus (Drug) $10.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.